Amicus Therapeutics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
363.00
1,224.00
-
4,958.00
36,930.00
91,245
Cost of Goods Sold (COGS) incl. D&A
-
-
1,833.00
4,075.00
9,829.00
18,620
Gross Income
-
-
1,833.00
883.00
27,101.00
72,625
SG&A Expense
60,337.00
68,341.00
121,112.00
169,444.00
229,481.00
398,102
EBIT
61,693.00
68,664.00
122,945.00
168,561.00
202,380.00
325,477
Unusual Expense
1,580.00
37.00
8,444.00
26,931.00
239,870.00
6,039
Non Operating Income/Expense
-
77.00
80.00
4,493.00
6,273.00
5,632
Interest Expense
46.00
1,484.00
1,578.00
5,398.00
17,240.00
22,402
Pretax Income
63,145.00
70,039.00
132,118.00
203,781.00
449,121.00
349,089
Income Tax
3,512.00
1,113.00
-
3,739.00
165,119.00
94
Consolidated Net Income
59,633.00
68,926.00
132,118.00
200,042.00
284,002.00
348,995
Net Income
59,633.00
68,926.00
132,118.00
200,042.00
284,002.00
348,995
Net Income After Extraordinaries
59,633.00
68,926.00
132,118.00
200,042.00
284,002.00
348,995
Net Income Available to Common
59,633.00
68,926.00
132,118.00
200,042.00
284,002.00
348,995
EPS (Basic)
1.16
0.93
1.20
1.49
1.85
1.88
Basic Shares Outstanding
51,286.10
74,444.20
109,923.80
134,401.60
153,355.10
185,790
EPS (Diluted)
1.16
0.93
1.20
1.49
1.85
1.88
Diluted Shares Outstanding
51,286.10
74,444.20
109,923.80
134,401.60
153,355.10
185,790
EBITDA
59,974.00
67,117.00
121,112.00
165,319.00
198,787.00
321,261
Non-Operating Interest Income
174.00
223.00
929.00
1,602.00
4,096.00
10,461
About Amicus Therapeutics
View Profile
